Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan P Janssens

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
European Journal of Heart Failure|September 24, 2010
Granulocyte colony-stimulating factor in cardiac repair: time for a reappraisal?Stefan P Janssens
Journal of the American College of Cardiology|February 4, 2017
Mesenchymal Cell Therapy for Dilated Cardiomyopathy: Time to Test the WaterStefan P Janssens
European Heart Journal|June 7, 2011
Cardiac bone marrow cell therapy: the proof of the pudding remains in the eatingStefan P Janssens
Current Atherosclerosis Reports|April 2, 2003
Applied gene therapy in preclinical models of vascular injuryStefan P Janssens
Circulation Research|August 19, 2007
How old is your heart?Karin R Sipido, Stefan P Janssens
Circulation|July 31, 2002
Defining gene transfer before expecting gene therapy: putting the horse before the cartSorin Pislaru, Stefan P Janssens, Bernard J Gersh, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 31, 2011
Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategyYixuan Zhang, Stefan P Janssens, Kirstin Wingler, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 2, 2015
Concomitant Phosphodiesterase 5 Inhibition Enhances Myocardial Protection by Inhaled Nitric Oxide in Ischemia-Reperfusion InjuryArpad Lux, Peter Pokreisz, Melissa Swinnen, et al.
Frontiers in Cardiovascular Medicine|April 22, 2024
Inhaled NO at a crossroads in cardiac surgery: current need to improve mechanistic understanding, clinical trial design and scientific evidenceStefan Muenster, Iratxe Zarragoikoetxea, Andrea Moscatelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 2013
Fetal rat hearts do not display acute cardiotoxicity in response to maternal Doxorubicin treatmentMina Mhallem Gziri, Peter Pokreisz, Rita De Vos, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
European Journal of Heart Failure|September 24, 2010
Granulocyte colony-stimulating factor in cardiac repair: time for a reappraisal?Stefan P Janssens
Journal of the American College of Cardiology|February 4, 2017
Mesenchymal Cell Therapy for Dilated Cardiomyopathy: Time to Test the WaterStefan P Janssens
European Heart Journal|June 7, 2011
Cardiac bone marrow cell therapy: the proof of the pudding remains in the eatingStefan P Janssens
Current Atherosclerosis Reports|April 2, 2003
Applied gene therapy in preclinical models of vascular injuryStefan P Janssens
Circulation Research|August 19, 2007
How old is your heart?Karin R Sipido, Stefan P Janssens
Circulation|July 31, 2002
Defining gene transfer before expecting gene therapy: putting the horse before the cartSorin Pislaru, Stefan P Janssens, Bernard J Gersh, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 31, 2011
Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategyYixuan Zhang, Stefan P Janssens, Kirstin Wingler, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 2, 2015
Concomitant Phosphodiesterase 5 Inhibition Enhances Myocardial Protection by Inhaled Nitric Oxide in Ischemia-Reperfusion InjuryArpad Lux, Peter Pokreisz, Melissa Swinnen, et al.
Frontiers in Cardiovascular Medicine|April 22, 2024
Inhaled NO at a crossroads in cardiac surgery: current need to improve mechanistic understanding, clinical trial design and scientific evidenceStefan Muenster, Iratxe Zarragoikoetxea, Andrea Moscatelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 2013
Fetal rat hearts do not display acute cardiotoxicity in response to maternal Doxorubicin treatmentMina Mhallem Gziri, Peter Pokreisz, Rita De Vos, et al.
Pageof 3